financetom
Business
financetom
/
Business
/
Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints New reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints New reports
Nov 4, 2025 7:55 AM

Nov 4 (Reuters) - Eli Lilly ( LLY ) and Novo Nordisk

are preparing to announce new drug pricing deals with

the White House, including for their blockbuster weight loss

drugs, in return for coverage of products under Medicare,

Endpoints New reported on Tuesday, citing sources familiar with

the matter.

(Reporting by Sriparna Roy in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved